Focal boost SBRT in men with intermediate- and high-risk PCa: 5-year results of the hypo-FLAME trial

被引：0
|
作者：
Draulans, Cedric [1 ]
Haustermans, Karin [1 ,2 ]
Pos, Floris J. [3 ]
van der Heide, Uulke A. [3 ]
De Cock, Lisa [1 ]
van Zyp, Jochem R. N. Van der Voort [4 ]
de Boer, Hans C. J. [4 ]
Smeenk, Robert Jan [5 ]
Kunze-Busch, Martina [5 ]
Monninkhof, Evelyn M. [6 ]
De Roover, Robin [2 ]
Isebaert, Sofie [2 ]
Kerkmeijer, Linda G. W. [4 ,5 ]
机构：
[1] Katholieke Univ Leuven, Dept Oncol, Leuven, Belgium
[2] Univ Hosp Leuven, Dept Radiat Oncol, Leuven, Belgium
[3] Netherlands Canc Inst, Dept Radiat Oncol, Amsterdam, Netherlands
[4] Univ Med Ctr Utrecht, Dept Radiat Oncol, Utrecht, Netherlands
[5] Radboud Univ Nijmegen Med Ctr, Dept Radiat Oncol, Nijmegen, Netherlands
[6] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands
来源：
RADIOTHERAPY AND ONCOLOGY | 2024年 / 194卷
关键词：
Prostate cancer; SBRT; Focal boost;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3396
引用
收藏
页码：S2647 / S2649
页数：4
相关论文
共 50 条
  • [1] Stereotactic body radiotherapy with a focal boost to the intraprostatic tumor for intermediate and high risk prostate cancer: 5-year efficacy and toxicity in the hypo-FLAME trial
    Draulans, Cedric
    Haustermans, Karin
    Pos, Floris J.
    van der Heide, Uulke A.
    De Cock, Lisa
    van Zyp, Jochem van der Voort
    De Boer, Hans
    Smeenk, Robert J.
    Kunze-Busch, Martina
    Monninkhof, Evelyn M.
    De Roover, Robin
    Isebaert, Sofie
    Kerkmeijer, Linda G. W.
    RADIOTHERAPY AND ONCOLOGY, 2024, 201
  • [2] Primary endpoint analysis of the multicentre phase II hypo-FLAME trial for intermediate and high risk prostate cancer
    Draulans, Cedric
    van der Heide, Uulke A.
    Haustermans, Karin
    Pos, Floris J.
    van Zyp, Jochem van der Voort
    De Boer, Hans
    Groen, Veerle H.
    Monninkhof, Evelyn M.
    Smeenk, Robert J.
    Kunze-Busch, Martina
    De Roover, Robin
    Depuydt, Tom
    Isebaert, Sofie
    Kerkmeijer, Linda G. W.
    RADIOTHERAPY AND ONCOLOGY, 2020, 147 : 92 - 98
  • [3] Outcomes of Hypofractionated SBRT Boost for Intermediate- and High-Risk Prostate Cancer: A Single Institutional Prospective Study
    Anwar, M.
    Weinberg, V.
    Hsu, I. J.
    Roach, M.
    Gottschalk, A. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S105 - S106
  • [4] Stereotactic radiotherapy with focal boost for intermediate and high-risk prostate cancer: Initial results of the SPARC trial
    Nicholls, Luke
    Suh, Yae-eun
    Chapman, Ewan
    Henderson, Daniel
    Jones, Caroline
    Morrison, Kirsty
    Sohaib, Aslam
    Taylor, Helen
    Tree, Alison
    van As, Nicholas
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2020, 25 : 88 - 93
  • [5] SBRT Boost for Intermediate and High-Risk Prostate Cancer. Results of a single Chilean institution
    Sanchez, M. F.
    Bakal, F.
    Troncoso, A.
    Bettoli, P.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S1175 - S1176
  • [6] Ultra-hypofractionated versus Conventionally Fractionated Radiation Therapy Boost for Patients with High-Risk, Localized Prostate Cancer: A 5-Year Results from Randomized HYPO-PROST Trial
    Milecki, P., II
    Antczak, A.
    Milecki, T.
    Gluszak, P.
    Piotrowski, T. G.
    Rucinska, A.
    Malicki, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S62 - S63
  • [7] Ten Year Results of Extensive Nodal Radiotherapy and Moderately Hypofractionated Simultaneous Integrated Boost in Unfavorable Intermediate-, High-, and Very High-Risk Prostate Cancer
    Di Muzio, Nadia Gisella
    Deantoni, Chiara Lucrezia
    Brombin, Chiara
    Fiorino, Claudio
    Cozzarini, Cesare
    Zerbetto, Flavia
    Mangili, Paola
    Tummineri, Roberta
    Dell'Oca, Italo
    Broggi, Sara
    Pasetti, Marcella
    Chiara, Anna
    Rancoita, Paola Maria Vittoria
    Del Vecchio, Antonella
    Di Serio, Mariaclelia Stefania
    Fodor, Andrei
    CANCERS, 2021, 13 (19)
  • [8] HDR brachytherapy boost using MR-only workflow for intermediate- and high-risk prostate cancer: 8-year results of a pilot study
    Lakosi, Ferenc
    Antal, Gergely
    Pall, Janos
    Farkas, Andrea
    Jenei, Tibor
    Nagy, Denes
    Liptak, Jozsef
    Sipocz, Istvan
    Pytel, Akos
    Csima, Melinda
    Gulyban, Akos
    Toller, Gabor
    BRACHYTHERAPY, 2021, 20 (03) : 576 - 583
  • [9] High-dose-rate brachytherapy as monotherapy for intermediate- and high-risk prostate cancer: Seven-year results
    Yoshioka, Y.
    Suzuki, O.
    Nakai, Y.
    Uemura, M.
    Nonomura, N.
    Ogawa, K.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S124 - S124
  • [10] Establishing Predictors of Satellite Lesions in Men With Intermediate- and High-Risk Prostate Cancer for Improved Patient Selection for Focal and Focused Therapy
    Hegde, J. V.
    Wang, J.
    Margolis, D.
    Huang, J.
    Kamrava, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E237 - E237
12345